Join the Pancreatic Cancer group to help and get support from people like you.
Pancreatic Cancer News
Related terms: Cancer, Pancreas, Cancer, Pancreatic, Pancreatic Carcinoma
Scientists Find Way to Reverse Chemo Resistance in Pancreatic Cancer Patients
MONDAY, July 8, 2024 – Pancreatic cancer is particularly aggressive and difficult to treat, partly because it’s often resistant to chemotherapy. Researchers now think they know why chemo struggles t...
Perioperative Chemo Improves Progression-Free Survival in Pancreatic Cancer
TUESDAY, July 2, 2024 – For patients with resectable pancreatic ductal adenocarcinoma (PDAC), the 12-month progression-free survival (PFS) may be increased with neoadjuvant modified 5-fluorouracil,...
Timing of Chemo Could Be Key to Pancreatic Cancer Outcomes
MONDAY, June 24, 2024 – Giving people with pancreatic cancer chemotherapy both before and after a tumor-removing surgery brought better outcomes than if they got the drugs only after the surgery,...
Most Cancer Treatments Near End of Life Are Useless: Study
FRIDAY, May 17, 2024 – Cutting-edge cancer treatments are essentially useless for patients barely clinging to life, a new study shows. Chemotherapies, immunotherapies, targeted therapies and hormone...
American Association for Cancer Research, April 5-10
The annual meeting of the American Association for Cancer Research was held this year from April 5 to 10 in San Diego, drawing approximately 19,000 participants from around the world, including...
Subclassification Can Tailor Surveillance for Pancreatic Adenocarcinoma
WEDNESDAY, April 17, 2024 – Subclassification of individuals at high risk for pancreatic adenocarcinoma (PC) can enable the development of surveillance approaches better tailored to risk, according...
AACR: Exosome-Based miRNA Assay Can Detect Pancreatic Cancer
MONDAY, April 8, 2024 – An exosome-based liquid biopsy assay can distinguish patients with pancreatic ductal adenocarcinoma (PDAC) from healthy donors (HDs), according to a study presented at the...
Immunotherapy Before Surgery Might Boost Pancreatic Cancer Survival
MONDAY, April 8, 2024 – Pancreatic cancer patients may do better if they receive an immunotherapy drug as well as chemotherapy in preparation for surgery, new research suggests. Pancreatic cancer is...
Therapeutic Vaccine Prevents Pancreatic Cancer's Recurrence in 3-Year Trial
MONDAY, April 8, 2024 – A pancreatic cancer vaccine has continued to protect a small group of patients from their cancer coming back, three years after receiving the jab, a new study says. Eight...
Blood Test Spots Early Pancreatic Cancers With 97% Accuracy
MONDAY, April 8, 2024 – A blood test appears capable of detecting early-stage pancreatic cancers with up to 97% accuracy, a new study reports. The test looks for eight small RNA particles and eight...
FDA Approves Onivyde Combination for Metastatic Pancreatic Cancer
THURSDAY, Feb. 15, 2024 – The U.S. Food and Drug Administration has approved Onivyde (irinotecan liposome injection) plus oxaliplatin, fluorouracil, and leucovorin (NALIRIFOX) as a first-line...
Ipsen’s Onivyde Regimen, a Potential New Standard-of-Care First-Line Therapy in Metastatic Pancreatic Adenocarcinoma, Approved by FDA
PARIS, FRANCE, 13 February 2024 – Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental new drug application for Onivyde (...
Five-Year Survival for Pancreatic Cancer Has Risen to 13%
THURSDAY, Jan. 18, 2024 – Pancreatic cancer is known as a 'silent killer' because it's usually only detected in its later stages. But there's a glimmer of good news for patients: The five-year...
Cancer Vaccine Safe, Induces T-Cell Responses for KRAS-Mutated Tumors
FRIDAY, Jan. 12, 2024 – For patients with immunotherapy recalcitrant KRAS-mutated tumors, the cancer vaccine ELI-002 2P is safe and induces T-cell responses, according to a study published online...
Therapeutic Vaccine Could Fight Pancreatic Cancer
TUESDAY, Jan.9, 2024 – Patients with the most common form of pancreatic cancer could benefit from an experimental therapeutic vaccine, a small new clinical trial shows. The vaccine, called ELI-002...
Ask a question
To post your own question to this support group, sign in or create an account.